Search

The prevalence of type 2 diabetes mellitus (T2DM) has been increasing worldwide, and it is becoming a public health concern. In this book, the pathophysiological risk factors of progression from normoglycemia to prediabetes and the lifestyle modifications and pharmacological interventions for preventing or delaying the development of glucose intolerance is examined. Furthermore, the insulin signaling pathway regulates the cellular uptake of glucose and wholebody metabolic homeostasis in mammalians. This book explores the improvement of estrogen signaling in preventing the comorbidities of insulin resistance. The next chapter focuses on nutritional management during the perioperative period, focusing on glucose metabolism and insulin sensitivity. There are three major problems for nutritional management during the perioperative period. These problems are addressed and suggestions are made on how to alleviate them. Finally, Cystic Fibrosis (CF) is the most common lethal inherited disorder in Caucasians, affecting 1 in 2,500 - 2,800 live births. The last chapter examines impaired glucose tolerance in cystic fibrosis.

Insulin resistance (IR) and metabolic syndrome are associated with the pathogenesis and progression of non-alcoholic fatty liver disease (NAFLD). It encompasses a spectrum of hepatic pathology, ranging from simple steatosis in its most benign form (fatty liver), going through nonalcoholic steatohepatitis (NASH) in its intermediate form, until cirrhosis and hepatocellular carcinoma, its most advanced forms. This new book presents current research on the background of fatty acid oxidation; hepatic steatosis and its progression to NASH and cirrhosis; fibrosis and myofibroblastic cells differentiation; methods of diagnosis; clinical features and laboratory tests and, finally, rodent NAFLD and NASH models.

Despite dizzyingly fast-paced advances over the past two decades, even the definition of Polycystic Ovarian Syndrome (PCOS) remains in dispute. Insulin Resistance and Polycystic Ovarian Syndrome: Pathogenesis, Evaluation, and Treatment highlights the recent transition of PCOS from an infertility disorder with a diagnosis based on ovarian tissue histology to a more complex clinical entity, a metabolic disorder in which insulin resistance plays a central role. With an expert panel of authors, each chapter provides an up-to-date and balanced overview of PCOS, paying special attention to the central role of insulin resistance in the syndrome's pathogenesis and in the management of its reproductive and metabolic abnormalities. Comprehensive and thought-provoking, Insulin Resistance and Polycystic Ovarian Syndrome: Pathogenesis, Evaluation, and Treatment is an invaluable resource for endocrinologists, gynecologists, and internists eager to learn more about this controversial and challenging disease.